Gene therapy is used as a treatment option for most of the chronic diseases like cancers, genetic disorders, cardiovascular diseases, and infectious pathogen neurological disorders. It involves the insertion of a functional copy of a gene into a defective cell. Viral vectors are tools used by molecular biologists in the efficient transfer of therapeutic gene into the target cells.
The major factors driving the market are an increase in funding, pipeline researches in various phases of clinical progression, the ability of vectors to express therapeutic genes efficiently, and nonpathogenic nature of vectors. The high price of gene therapies, short shelf-life of viral vectors, and possible risk of mutagenesis are going to restrain the market over the period of forecast.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
